Diamond Biofund Inc. (TPE:6901)

Diamond Biofund Statistics

Total Valuation

Diamond Biofund has a market cap or net worth of TWD 11.94 billion. The enterprise value is 8.14 billion.

Market Cap	11.94B
Enterprise Value	8.14B

Important Dates

The last earnings date was Monday, November 10, 2025.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Diamond Biofund has 852.75 million shares outstanding. The number of shares has increased by 0.18% in one year.

Current Share Class	852.75M
Shares Outstanding	852.75M
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	+0.06%
Owned by Insiders (%)	25.21%
Owned by Institutions (%)	4.38%
Float	230.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	-11.12
PB Ratio	1.29
P/TBV Ratio	1.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-6.93
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.81

Financial Position

The company has a current ratio of 56.91, with a Debt / Equity ratio of 0.01.

Current Ratio	56.91
Quick Ratio	56.87
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.36
Interest Coverage	-395.46

Financial Efficiency

Return on equity (ROE) is -11.99% and return on invested capital (ROIC) is -23.32%.

Return on Equity (ROE)	-11.99%
Return on Assets (ROA)	-7.62%
Return on Invested Capital (ROIC)	-23.32%
Return on Capital Employed (ROCE)	-13.15%
Weighted Average Cost of Capital (WACC)	11.39%
Revenue Per Employee	-32.52M
Profits Per Employee	-35.60M
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Diamond Biofund has paid 918,000 in taxes.

Income Tax	918,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -52.70% in the last 52 weeks. The beta is 1.31, so Diamond Biofund's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-52.70%
50-Day Moving Average	16.23
200-Day Moving Average	18.33
Relative Strength Index (RSI)	33.19
Average Volume (20 Days)	592,708

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Diamond Biofund had revenue of TWD -1.07 billion and -1.17 billion in losses. Loss per share was -1.38.

Revenue	-1.07B
Gross Profit	-1.07B
Operating Income	-1.22B
Pretax Income	-1.17B
Net Income	-1.17B
EBITDA	-1.21B
EBIT	-1.22B
Loss Per Share	-1.38

Balance Sheet

The company has 3.89 billion in cash and 93.93 million in debt, with a net cash position of 3.80 billion or 4.45 per share.

Cash & Cash Equivalents	3.89B
Total Debt	93.93M
Net Cash	3.80B
Net Cash Per Share	4.45
Equity (Book Value)	9.22B
Book Value Per Share	10.81
Working Capital	3.84B

Cash Flow

In the last 12 months, operating cash flow was -264.06 million and capital expenditures -189,000, giving a free cash flow of -264.25 million.

Operating Cash Flow	-264.06M
Capital Expenditures	-189,000
Depreciation & Amortization	7.41M
Net Borrowing	-23.90M
Free Cash Flow	-264.25M
FCF Per Share	-0.31

Margins

Gross Margin	n/a
Operating Margin	113.78%
Pretax Margin	109.37%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Diamond Biofund does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.18%
Shareholder Yield	-0.18%
Earnings Yield	-9.84%
FCF Yield	-2.21%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 1.18.

Last Split Date	Aug 7, 2023
Split Type	Forward
Split Ratio	1.18

Scores

Diamond Biofund has an Altman Z-Score of 82.73 and a Piotroski F-Score of 2.

Altman Z-Score	82.73
Piotroski F-Score	2